IntraLase & Escalon on better terms

Article

IntraLase has entered into an agreement with Escalon Medical to settle all outstanding disputes and litigation between the parties.

IntraLase has entered into an agreement with Escalon Medical to settle all outstanding disputes and litigation between the parties.

Under the terms of the agreement, IntraLase will make a payment of $9.6 million to Escalon, in exchange for all pending litigations to be dropped. Full ownership of all patents and intellectual property formerly licensed from Escalon will be obtained by IntraLase and all IntraLase obligations under the parties' license agreement will terminate. The payment will also cover all outstanding royalties owed or alleged to be owed by IntraLase to Escalon.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.